India, July 22 -- Quantum BioPharma Ltd. (QNTM), Tuesday announced the purchase of 2,000 shares of GameStop Corp. (GME), making a strategic move in line with the company's commitment to combating market corruption and enhancing shareholder value.
Moreover, the move signifies a further step in deploying capital toward undervalued assets with strong fundamentals, reflecting the company's disciplined approach to asset management amid its core focus on developing treatments like Lucid-MS for multiple sclerosis.
In the pre-market hours, QNTM is trading at $24.05, up 1.43 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....